Telix Pharmaceuticals Earnings Estimate

By analyzing Telix Pharmaceuticals' earnings estimates, investors can diagnose different trends across Telix Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Telix Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options. Telix Pharmaceuticals is projected to generate 0.01 in earnings per share on the 31st of December 2023. Telix Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected Telix Pharmaceuticals EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Telix Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Telix Pharmaceuticals' earnings estimates, investors can diagnose different trends across Telix Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 323.9 M in 2024Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.